440 related articles for article (PubMed ID: 29260505)
21. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
Eiland LS; English TM; Eiland EH
Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
[TBL] [Abstract][Full Text] [Related]
22. Optimizing the Clinical Use of Vancomycin.
Álvarez R; López Cortés LE; Molina J; Cisneros JM; Pachón J
Antimicrob Agents Chemother; 2016 May; 60(5):2601-9. PubMed ID: 26856841
[TBL] [Abstract][Full Text] [Related]
23. Optimisation of vancomycin exposure in neonates based on the best level of evidence.
Dao K; Guidi M; André P; Giannoni E; Basterrechea S; Zhao W; Fuchs A; Pfister M; Buclin T; Csajka C
Pharmacol Res; 2020 Apr; 154():104278. PubMed ID: 31108184
[TBL] [Abstract][Full Text] [Related]
24. Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients.
Bel Kamel A; Bourguignon L; Marcos M; Ducher M; Goutelle S
Ther Drug Monit; 2017 Feb; 39(1):83-87. PubMed ID: 27861313
[TBL] [Abstract][Full Text] [Related]
25. Achievement of Therapeutic Vancomycin Exposure With Continuous Infusion in Critically Ill Children.
Genuini M; Oualha M; Bouazza N; Moulin F; Treluyer JM; Lesage F; Renolleau S; Benaboud S
Pediatr Crit Care Med; 2018 Jun; 19(6):e263-e269. PubMed ID: 29394210
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic monitoring of vancomycin in routine clinical practice].
Kacířová I; Grundmann M
Vnitr Lek; 2014 Oct; 60(10):846-51. PubMed ID: 25382007
[TBL] [Abstract][Full Text] [Related]
27. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
[TBL] [Abstract][Full Text] [Related]
28. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
[TBL] [Abstract][Full Text] [Related]
29. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
[TBL] [Abstract][Full Text] [Related]
30. A higher dose of vancomycin in continuous infusion is needed in critically ill patients.
Jeurissen A; Sluyts I; Rutsaert R
Int J Antimicrob Agents; 2011 Jan; 37(1):75-7. PubMed ID: 21074374
[TBL] [Abstract][Full Text] [Related]
31. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals.
Davis SL; Scheetz MH; Bosso JA; Goff DA; Rybak MJ
Pharmacotherapy; 2013 Dec; 33(12):1256-63. PubMed ID: 23897602
[TBL] [Abstract][Full Text] [Related]
32. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a pediatric continuous-infusion vancomycin therapy guideline.
McKamy S; Chen T; Lee M; Ambrose PJ
Am J Health Syst Pharm; 2012 Dec; 69(23):2066-71. PubMed ID: 23172265
[TBL] [Abstract][Full Text] [Related]
34. Prospective Trial on the Use of Trough Concentration versus Area under the Curve To Determine Therapeutic Vancomycin Dosing.
Neely MN; Kato L; Youn G; Kraler L; Bayard D; van Guilder M; Schumitzky A; Yamada W; Jones B; Minejima E
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203493
[TBL] [Abstract][Full Text] [Related]
35. Pitfalls in dosing vancomycin.
Koppula S; Ruben S; Bangash F; Szerlip HM
Am J Med Sci; 2015 Feb; 349(2):137-9. PubMed ID: 25437128
[TBL] [Abstract][Full Text] [Related]
36. Implementation of a protocol for administration of vancomycin by continuous infusion: pharmacokinetic, pharmacodynamic and toxicological aspects.
Ampe E; Delaere B; Hecq JD; Tulkens PM; Glupczynski Y
Int J Antimicrob Agents; 2013 May; 41(5):439-46. PubMed ID: 23523733
[TBL] [Abstract][Full Text] [Related]
37. Design and prospective validation of a dosing instrument for continuous infusion of vancomycin: a within-population approach.
van Maarseveen EM; Bouma A; Touw DJ; Neef C; van Zanten AR
Eur J Clin Pharmacol; 2014 Nov; 70(11):1353-9. PubMed ID: 25168621
[TBL] [Abstract][Full Text] [Related]
38. Importance of vancomycin loading doses in intermittent infusion regimens.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Infect Chemother; 2018 Apr; 24(4):247-250. PubMed ID: 29195829
[TBL] [Abstract][Full Text] [Related]
39. Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient.
Moffett BS; Ivaturi V; Morris J; Akcan Arikan A; Dutta A
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745380
[TBL] [Abstract][Full Text] [Related]
40. An update on vancomycin dosing and monitoring practices in hemodialysis patients.
Zhang M; Dresser L; Battistella M
CANNT J; 2013; 23(4):25-7; quiz 28-9. PubMed ID: 24660521
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
